rs1131690902
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000321.3(RB1):c.380+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000000701 in 1,427,292 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000321.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.380+1G>A | splice_donor_variant, intron_variant | Intron 3 of 26 | ENST00000267163.6 | NP_000312.2 | ||
RB1 | NM_001407165.1 | c.380+1G>A | splice_donor_variant, intron_variant | Intron 3 of 26 | NP_001394094.1 | |||
RB1 | NM_001407166.1 | c.380+1G>A | splice_donor_variant, intron_variant | Intron 3 of 16 | NP_001394095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.380+1G>A | splice_donor_variant, intron_variant | Intron 3 of 26 | 1 | NM_000321.3 | ENSP00000267163.4 | |||
RB1 | ENST00000467505.5 | n.138-17302G>A | intron_variant | Intron 1 of 2 | 1 | ENSP00000434702.1 | ||||
RB1 | ENST00000650461.1 | c.380+1G>A | splice_donor_variant, intron_variant | Intron 3 of 26 | ENSP00000497193.1 | |||||
RB1 | ENST00000525036.1 | n.542+1G>A | splice_donor_variant, intron_variant | Intron 3 of 6 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.01e-7 AC: 1AN: 1427292Hom.: 0 Cov.: 26 AF XY: 0.00000140 AC XY: 1AN XY: 711992
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Retinoblastoma Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site results in skipping of exon 3 and introduces a premature termination codon (Invitae). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 428727). Disruption of this splice site has been observed in individual(s) with bilateral retinoblastoma (PMID: 22963398). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 3 of the RB1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.380+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide after coding exon 3 of the RB1 gene. This mutation has been reported in multiple individuals with bilateral retinoblastoma (Seo SH et al. Clin. Genet. 2013 May; 83(5):494-6; Yilmaz S et al. Hum. Mutat. 1998 ; 12(6):434). Of note, this mutation has been reported as IVS3+1G>A in the published literature. In addition to the clinical data presented in the literature, since alterations that disrupt the canonical splice donor site are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at